CrossrefInfokarte
Association of adverse effects with monoamine oxidase type B inhibitor and catechol-o-methyl transferase inhibitor combination therapy in Parkinson’s disease patients
Advances in Parkinson's Disease · 2012
DOI: 10.4236/apd.2012.11002 ↗Abstract
Kein Abstract verfügbar.
EUVIMED